ProfileGDS4718 / 1553880_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 38% 34% 39% 33% 36% 35% 37% 40% 34% 36% 28% 34% 34% 34% 33% 31% 30% 29% 35% 36% 38% 36% 33% 30% 36% 32% 33% 38% 33% 36% 33% 34% 38% 31% 35% 33% 45% 35% 31% 34% 31% 37% 33% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.890238
GSM549102patient 115, normal, homogenized [OPG study]4.9221338
GSM549104patient 119, normal, homogenized [OPG study]4.721334
GSM549108patient 138, normal, homogenized [OPG study]5.0013439
GSM549119patient 077, normal, homogenized [OPG study]4.667133
GSM549133patient 032, cancer, homogenized [OPG study]4.7374736
GSM549139patient 042, cancer, homogenized [OPG study]4.7598135
GSM549099patient 107, normal, homogenized [OPG study]4.8676637
GSM549109patient 139, normal, homogenized [OPG study]4.9941840
GSM549110patient 046, normal, homogenized [OPG study]4.7379634
GSM549114patient 063, normal, homogenized [OPG study]4.7536236
GSM549122patient 082, normal, homogenized [OPG study]4.446928
GSM549134patient 033, cancer, homogenized [OPG study]4.7079334
GSM549136patient 036, cancer, homogenized [OPG study]4.6328334
GSM549140patient 044, cancer, homogenized [OPG study]4.6815834
GSM549111patient 047, normal, homogenized [OPG study]4.6402433
GSM549113patient 057, normal, homogenized [OPG study]4.5353131
GSM549132patient 031, cancer, homogenized [OPG study]4.5403430
GSM549137patient 038, cancer, homogenized [OPG study]4.4724929
GSM549142patient 047, cancer, homogenized [OPG study]4.8577835
GSM549100patient 110, normal, homogenized [OPG study]4.8395536
GSM549107patient 135, normal, homogenized [OPG study]4.8433338
GSM549115patient 068, normal, homogenized [OPG study]4.7587736
GSM549116patient 072, normal, homogenized [OPG study]4.655433
GSM549120patient 078, normal, homogenized [OPG study]4.5532530
GSM549131patient 030, cancer, homogenized [OPG study]4.7522136
GSM549118patient 074, normal, homogenized [OPG study]4.621432
GSM549129patient 027, cancer, homogenized [OPG study]4.6858133
GSM549123patient 088, normal, homogenized [OPG study]4.8638838
GSM549124patient 006, cancer, homogenized [OPG study]4.7095833
GSM549126patient 015, cancer, homogenized [OPG study]4.7816636
GSM549128patient 025, cancer, homogenized [OPG study]4.6346733
GSM549103patient 117, normal, homogenized [OPG study]4.7908834
GSM549117patient 073, normal, homogenized [OPG study]4.8758138
GSM549138patient 041, cancer, homogenized [OPG study]4.5615431
GSM549141patient 045, cancer, homogenized [OPG study]4.6736135
GSM549130patient 028, cancer, homogenized [OPG study]4.6770933
GSM549101patient 111, normal, homogenized [OPG study]5.2517145
GSM549105patient 128, normal, homogenized [OPG study]4.7873435
GSM549106patient 134, normal, homogenized [OPG study]4.5333131
GSM549112patient 048, normal, homogenized [OPG study]4.7235834
GSM549125patient 011, cancer, homogenized [OPG study]4.6072931
GSM549127patient 024, cancer, homogenized [OPG study]4.8310537
GSM549135patient 035, cancer, homogenized [OPG study]4.6304933